Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CXSL2300501	ELPIS人脐带间充质干细胞注射液	Injection	Biological Products(1)	New Drug Application	2023-07-21		view
CXSL2300030	ELPIS人脐带间充质干细胞注射液	Injection	Biological Products(1)	New Drug Application	2023-01-11	Huaxiayuan (Shanghai) Biotechnology Co Ltd	view
CXSL2200581	ELPIS人脐带间充质干细胞注射液	Injection	Biological Products(1)	New Drug Application	2022-11-18	Huaxiayuan (Shanghai) Biotechnology Co Ltd	view
CXSL2200142	ELPIS人脐带间充质干细胞注射液	Injection	Biological Products(1)	New Drug Application	2022-03-24	Huaxiayuan (Shanghai) Biotechnology Co Ltd	view
CXSL2101224	ELPIS人脐带间充质干细胞注射液	Injection	Biological Products(1)	New Drug Application	2021-07-30	Huaxiayuan Cell Engineering Group Co Ltd	view